Memphis Pharmaceuticals & Chemical Industries reported earnings results for the nine months ended March 31, 2023. For the nine months, the company reported sales was EGP 440.47 million compared to EGP 406.51 million a year ago. Net income was EGP 35.06 million compared to EGP 21 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
79.64 EGP | -0.80% | -16.39% | +27.00% |
1st Jan change | Capi. | |
---|---|---|
+27.00% | 9.53M | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+7.09% | 166B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2023